These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
221 related items for PubMed ID: 17308083
1. Possible role of semaphorin 3F, a candidate tumor suppressor gene at 3p21.3, in p53-regulated tumor angiogenesis suppression. Futamura M, Kamino H, Miyamoto Y, Kitamura N, Nakamura Y, Ohnishi S, Masuda Y, Arakawa H. Cancer Res; 2007 Feb 15; 67(4):1451-60. PubMed ID: 17308083 [Abstract] [Full Text] [Related]
2. Semaphorin SEMA3F affects multiple signaling pathways in lung cancer cells. Potiron VA, Sharma G, Nasarre P, Clarhaut JA, Augustin HG, Gemmill RM, Roche J, Drabkin HA. Cancer Res; 2007 Sep 15; 67(18):8708-15. PubMed ID: 17875711 [Abstract] [Full Text] [Related]
3. Semaphorin SEMA3F has a repulsing activity on breast cancer cells and inhibits E-cadherin-mediated cell adhesion. Nasarre P, Kusy S, Constantin B, Castellani V, Drabkin HA, Bagnard D, Roche J. Neoplasia; 2005 Feb 15; 7(2):180-9. PubMed ID: 15802023 [Abstract] [Full Text] [Related]
4. [Mutation and expression of SEMA3B and SEMA3F gene in nasopharyngeal carcinoma]. Liu XQ, Sun M, Chen HK, Li JX, Pan ZG, Long QX, Wang XZ, Zeng YX. Ai Zheng; 2003 Jan 15; 22(1):16-20. PubMed ID: 12561429 [Abstract] [Full Text] [Related]
5. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver. Gray MJ, Van Buren G, Dallas NA, Xia L, Wang X, Yang AD, Somcio RJ, Lin YG, Lim S, Fan F, Mangala LS, Arumugam T, Logsdon CD, Lopez-Berestein G, Sood AK, Ellis LM. J Natl Cancer Inst; 2008 Jan 16; 100(2):109-20. PubMed ID: 18182619 [Abstract] [Full Text] [Related]
6. The ETS transcription factor MEF is a candidate tumor suppressor gene on the X chromosome. Seki Y, Suico MA, Uto A, Hisatsune A, Shuto T, Isohama Y, Kai H. Cancer Res; 2002 Nov 15; 62(22):6579-86. PubMed ID: 12438253 [Abstract] [Full Text] [Related]
7. Semaphorin-induced cytoskeletal collapse and repulsion of endothelial cells. Bielenberg DR, Shimizu A, Klagsbrun M. Methods Enzymol; 2008 Nov 15; 443():299-314. PubMed ID: 18772022 [Abstract] [Full Text] [Related]
8. Semaphorin 3F gene from human 3p21.3 suppresses tumor formation in nude mice. Xiang R, Davalos AR, Hensel CH, Zhou XJ, Tse C, Naylor SL. Cancer Res; 2002 May 01; 62(9):2637-43. PubMed ID: 11980661 [Abstract] [Full Text] [Related]
9. Expression of VEGF, semaphorin SEMA3F, and their common receptors neuropilins NP1 and NP2 in preinvasive bronchial lesions, lung tumours, and cell lines. Lantuéjoul S, Constantin B, Drabkin H, Brambilla C, Roche J, Brambilla E. J Pathol; 2003 Jul 01; 200(3):336-47. PubMed ID: 12845630 [Abstract] [Full Text] [Related]
10. Regulation of mTOR Signaling by Semaphorin 3F-Neuropilin 2 Interactions In Vitro and In Vivo. Nakayama H, Bruneau S, Kochupurakkal N, Coma S, Briscoe DM, Klagsbrun M. Sci Rep; 2015 Jul 09; 5():11789. PubMed ID: 26156437 [Abstract] [Full Text] [Related]
11. FOXQ1 is overexpressed in colorectal cancer and enhances tumorigenicity and tumor growth. Kaneda H, Arao T, Tanaka K, Tamura D, Aomatsu K, Kudo K, Sakai K, De Velasco MA, Matsumoto K, Fujita Y, Yamada Y, Tsurutani J, Okamoto I, Nakagawa K, Nishio K. Cancer Res; 2010 Mar 01; 70(5):2053-63. PubMed ID: 20145154 [Abstract] [Full Text] [Related]
12. Semaphorin3F down-regulates the expression of integrin alpha(v)beta3 and sensitizes multicellular tumor spheroids to chemotherapy via the neuropilin-2 receptor in vitro. Zheng C, Zhou Q, Wu F, Peng Q, Tang A, Liang H, Zeng Y. Chemotherapy; 2009 Mar 01; 55(5):344-52. PubMed ID: 19657188 [Abstract] [Full Text] [Related]
13. Neuropilins in neoplasms: expression, regulation, and function. Bielenberg DR, Pettaway CA, Takashima S, Klagsbrun M. Exp Cell Res; 2006 Mar 10; 312(5):584-93. PubMed ID: 16445911 [Abstract] [Full Text] [Related]
14. Evidence that Sema3A and Sema3F regulate the migration of GABAergic neurons in the developing neocortex. Tamamaki N, Fujimori K, Nojyo Y, Kaneko T, Takauji R. J Comp Neurol; 2003 Jan 06; 455(2):238-48. PubMed ID: 12454988 [Abstract] [Full Text] [Related]
15. Prognostic significance of VEGF-C, semaphorin 3F, and neuropilin-2 expression in oral squamous cell carcinomas and their relationship with lymphangiogenesis. Zhang B, Gao Z, Sun M, Li H, Fan H, Chen D, Zheng J. J Surg Oncol; 2015 Mar 15; 111(4):382-8. PubMed ID: 25475162 [Abstract] [Full Text] [Related]
16. Development of the somatosensory cortex, the cerebellum, and the main olfactory system in Semaphorin 3F knockout mice. Matsuda I, Fukaya M, Nakao H, Nakao K, Matsumoto H, Mori K, Watanabe M, Aiba A. Neurosci Res; 2010 Mar 15; 66(3):321-9. PubMed ID: 20006658 [Abstract] [Full Text] [Related]
17. Semaphorin-3F suppresses the stemness of colorectal cancer cells by inactivating Rac1. Rao J, Zhou ZH, Yang J, Shi Y, Xu SL, Wang B, Ping YF, Chen L, Cui YH, Zhang X, Wu F, Bian XW. Cancer Lett; 2015 Mar 01; 358(1):76-84. PubMed ID: 25529012 [Abstract] [Full Text] [Related]
19. Modulation of gene expression by tumor-derived p53 mutants. Scian MJ, Stagliano KE, Ellis MA, Hassan S, Bowman M, Miles MF, Deb SP, Deb S. Cancer Res; 2004 Oct 15; 64(20):7447-54. PubMed ID: 15492269 [Abstract] [Full Text] [Related]
20. Sequential arrival and graded secretion of Sema3F by olfactory neuron axons specify map topography at the bulb. Takeuchi H, Inokuchi K, Aoki M, Suto F, Tsuboi A, Matsuda I, Suzuki M, Aiba A, Serizawa S, Yoshihara Y, Fujisawa H, Sakano H. Cell; 2010 Jun 11; 141(6):1056-67. PubMed ID: 20550939 [Abstract] [Full Text] [Related] Page: [Next] [New Search]